Endocrinol Metab.  2020 Dec;35(4):784-785. 10.3803/EnM.2020.408.

A High Frequency of Lobectomy Instead of Total Thyroidectomy to Treat Medullary Thyroid Cancer in Korea: Data from the Korean National Health Insurance Service

• Cho SW

• KMID: 2511005
• DOI: http://doi.org/10.3803/EnM.2020.408

Reference

1. Wells SA Jr, Asa SL, Dralle H, Elisei R, Evans DB, Gagel RF, et al. Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma. Thyroid. 2015; 25:567–610.

2. Ahn HY, Chae JE, Moon H, Noh J, Park YJ, Kim SG. Trends in the diagnosis and treatment of patients with medullary thyroid carcinoma in Korea. Endocrinol Metab (Seoul). 2020; 35:811–9.

3. Jung KY, Kim SM, Kim MJ, Cho SW, Kim BW, Lee YS, et al. Genotypic characteristics and their association with phenotypic characteristics of hereditary medullary thyroid carcinoma in Korea. Surgery. 2018; 164:312–8.

4. Yip DT, Hassan M, Pazaitou-Panayiotou K, Ruan DT, Gawande AA, Gaz RD, et al. Preoperative basal calcitonin and tumor stage correlate with postoperative calcitonin normalization in patients undergoing initial surgical management of medullary thyroid carcinoma. Surgery. 2011; 150:1168–77.

5. Choi JB, Lee SG, Kim MJ, Kim TH, Ban EJ, Lee CR, et al. Dynamic risk stratification in medullary thyroid carcinoma: single institution experiences. Medicine (Baltimore). 2018; 97:e9686.